Article
Advances in acute myeloid leukemia differentiation therapy: A critical review
26 Jul 2023
Abstract excerpt
Acute myeloid leukemia (AML) is characterized by impaired differentiation and indefinite proliferation of abnormal myeloid progenitors. Although differentiating agents were deemed to revolutionize AML therapy, most treated non-APL AML patients are refractory or relapse. According to cancer stem cell model, leukemia-initiating cells are the root cause of relapse given their unidirectional potential to generate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
